无创呼吸支持与脑损伤机械通气患者拔管结局的关联
本研究为ENIO前瞻性观察研究的二次分析,纳入19国62家医院1115例急性脑损伤机械通气患者,其中267例(23.9%)拔管后接受预防性HFNC或NIPPV。与常规氧疗相比,预防性HFNC或NIPPV均与ICU期间再插管 odds 降低无关,OR分别为0.97(95%CI 0.54-1.73)和0.63(95%CI 0.30-1.32)。
要点
- 预防性HFNC或NIPPV未降低脑损伤患者拔管后再插管风险。
- NIPPV的OR为0.63但95%CI宽且跨1,不能认为有效。
- 需前瞻性试验确认该人群无创呼吸支持的治疗效应。
核心结论
- 在急性脑损伤拔管患者中,预防性HFNC和NIPPV均与再插管无关。
研究设计与样本
- ENIO前瞻性观察研究的二次分析,纳入62家医院1115例急性脑损伤机械通气患者。
主要发现
- 267例(23.9%)拔管后接受预防性HFNC或NIPPV。
- 与常规氧疗相比,HFNC再插管OR为0.97(95%CI 0.54-1.73)。
- 与常规氧疗相比,NIPPV再插管OR为0.63(95%CI 0.30-1.32)。
- 贝叶斯分析中HFNC降低再插管概率为17%至34%,NIPPV为46%至74%。
临床怎么用
- 脑损伤机械通气患者拔管后不应常规以预防再插管为目的使用HFNC或NIPPV。
局限性
- 为观察性研究的二次分析,不能确立因果。
- 预防性HFNC或NIPPV组样本量有限(267例)。
- 需前瞻性试验确认治疗效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Noninvasive respiratory support using a high-flow nasal cannula (HFNC) or noninvasive positive pressure ventilation (NIPPV) can decrease the risk of reintubation in patients being liberated from mechanical ventilation, but effects in patients with acute brain injury (ABI) are unknown. Objectives: To evaluate the association between postextubation noninvasive respiratory support and reintubation in patients with ABI being liberated from mechanical ventilation. Methods: This was a secondary analysis of a prospective, observational study of mechanically ventilated patients with ABI (clinicaltrials.gov identifier NCT03400904). The primary endpoint was reintubation during ICU admission. We used mixed-effects logistic regression models with patient-level covariates and random intercepts for hospital and country to evaluate the association between prophylactic (i.e., planned) HFNC or NIPPV and reintubation. Measurements and Main Results: 1,115 patients were included from 62 hospitals and 19 countries, of whom 267 received HFNC or NIPPV following extubation (23.9%). Compared with conventional oxygen therapy, neither prophylactic HFNC nor NIPPV was associated with decreased odds of reintubation (respectively, odds ratios of 0.97 [95% confidence interval, 0.54-1.73] and 0.63 [0.30-1.32]). Findings remained consistent in sensitivity analyses accounting for alternate adjustment procedures, missing data, shorter time frames of the primary endpoint, and competing risks precluding reintubation. In a Bayesian analysis using skeptical and data-driven priors, the probabilities of reduced reintubation ranged from 17% to 34% for HFNC and from 46% to 74% for NIPPV. Conclusions: In a large cohort of brain-injured patients undergoing liberation from mechanical ventilation, prophylactic use of HFNC and NIPPV were not associated with reintubation. Prospective trials are needed to confirm treatment effects in this population. Primary study registered with www.clinicaltrials.gov (NCT03400904).
引用
- Taran S, Diaz-Cruz C, Perrot B, et al. Association of Noninvasive Respiratory Support with Extubation Outcomes in Brain-injured Patients Receiving Mechanical Ventilation: A Secondary Analysis of the ENIO Prospective Observational Study. Am J Respir Crit Care Med. 2023. PMID: 37192445. doi:10.1164/rccm.202212-2249OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。